Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MEDRELEAF CORP T.LEAF

Healthcare Drug Manufacturers - Specialty & Generic
"MedReleaf Corp is engaged in the production and sale of cannabis for medical purposes as regulated by the ACMPR, pursuant to its Licences and, in particular, its Markham Commercial Licence."


TSX:LEAF - Post by User

MEDRELEAF CORP > Canopy aphria acb dont want medreleaf sorry
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(20)
•••
Comment by Muffet99on May 03, 2018 1:58pm
89 Views
Post# 27978007

RE:RE:RE:RE:Canopy aphria acb dont want medreleaf sorry

RE:RE:RE:RE:Canopy aphria acb dont want medreleaf sorry Cry cry cry buckshot26 i have 10,000 share in canopy and 11,000 in acb so dont tell me i dont know how to make money in investing lol ... Good luck with ur 200 shares in medreleaf ahagahah
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities